EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

The BioSynIRS trial: biologic versus synthetic mesh for multicompartment pelvic floor reconstruction

Claudia Rudroff, Luisa Halbe, Julia Schroer, Julius Ochel, Lars Daenenfaust, Axel Heidenreich, Sebastian Ludwig

Techniques in Coloproctology · 2026-12 · 30 (1)

DOI: 10.1007/s10151-026-03404-7 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Techniques in Coloproctology, online erschienen am 07.08.2026. Verfasst von Claudia Rudroff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Uro-Oncology, Interdisciplinary Continence and Pelvic Floor Center, University Hospital of Cologne and Medical Faculty Colo…. Hauptthemen laut MEDLINE: Surgical Mesh, Pelvic Organ Prolapse, Laparoscopy, Pelvic Floor. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Köln.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Selected patients with obstructed defecation syndrome (ODS) and concomitant pelvic organ prolapse (POP) may require laparoscopic resection rectopexy (L-RRP) with laparoscopic sacrocolpopexy (L-SCP). This trial compared the safety and efficacy of biologic versus synthetic mesh (BM or SM) in L-SCP.

Methods

In this single-center randomized pilot trial, 30 women with severe ODS underwent combined L-RRP and L-SCP using either a BM or SM. The primary endpoint was the severe adverse event rate. Secondary endpoints included functional and anatomical outcomes related to ODS and POP. Follow-up was complete at 12 months for all patients.

Results

The 30 patients (15 per group) had similar baseline characteristics, comparable frequency of additional surgical procedures, longer operative time in the SM group, lower pain in the BM group, similar length of hospital stay, comparable adverse event rates, and no mesh-related complications. Severe adverse events were reported by two patients (13%) in the BM group versus five (33%) in the SM group. Functional outcomes and POP-Q scores significantly improved in both groups ( p < 0.01), urinary incontinence was unchanged, and there were three cases of ODS recurrence at 12 months. The main limitation of this study is its pilot design with a limited sample size and short follow-up, precluding definitive conclusions regarding long-term durability and rare adverse events.

Conclusions

No significant differences in safety were detected between biologic and synthetic mesh; functional and anatomical outcomes improved similarly. Given the pilot design and limited sample size, these findings support the feasibility, but not equivalence or non-inferiority, of the biologic mesh. Adequately powered trials are required to confirm these findings and to evaluate the long-term durability of the biologic mesh.

Trial registration

Trial registration at ClinicalTrials.gov (NCT06245577) and at the German Clinical Trials Register (DRKS00033079).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surgical MeshPelvic Organ ProlapseLaparoscopyPelvic FloorConstipationPlastic Surgery ProceduresHumansFemaleAgedMiddle AgedPilot ProjectsTreatment OutcomePostoperative ComplicationsRectumSyndrome

Stichwörter der Autor:innen

Biologic productsFeasibility studyLaparoscopyObstructed defecation syndromePelvic organ prolapseSurgical mesh

Autor:innen und Institutionen

  • Department of Urology and Uro-Oncology, Interdisciplinary Continence and Pelvic Floor Center, University Hospital of Cologne and Medical Faculty Cologne, Kerpener Strasse 62, 50937, Cologne, Germany. claudia@rudroff.com.
  • Clinic for General and Visceral Surgery, Evangelisches Klinikum Köln Weyertal GmbH, Academic Teaching Hospital of the University of Cologne, Cologne, Germany. claudia@rudroff.com.
  • Department of Urology and Uro-Oncology, Interdisciplinary Continence and Pelvic Floor Center, University Hospital of Cologne and Medical Faculty Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
  • University of Cologne, Cologne, Germany.
  • Medical Faculty, University of Duesseldorf, Duesseldorf, Germany.
  • Institute for Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany.

Förderung

  • Universitätsklinikum Köln

Zitieren

APA

Rudroff, C., Halbe, L., Schroer, J., Ochel, J., Daenenfaust, L., Heidenreich, A., & Ludwig, S. (2026). The BioSynIRS trial: biologic versus synthetic mesh for multicompartment pelvic floor reconstruction. Techniques in Coloproctology, 30(1). https://doi.org/10.1007/s10151-026-03404-7

Vancouver

Rudroff C, Halbe L, Schroer J, Ochel J, Daenenfaust L, Heidenreich A, et al. The BioSynIRS trial: biologic versus synthetic mesh for multicompartment pelvic floor reconstruction. Techniques in Coloproctology. 2026;30(1). doi:10.1007/s10151-026-03404-7

BibTeX
@article{Rudroff2026,
  author = {Rudroff, Claudia and Halbe, Luisa and Schroer, Julia and Ochel, Julius and Daenenfaust, Lars and Heidenreich, Axel and Ludwig, Sebastian},
  title = {The BioSynIRS trial: biologic versus synthetic mesh for multicompartment pelvic floor reconstruction},
  journal = {Techniques in Coloproctology},
  year = {2026},
  volume = {30},
  number = {1},
  doi = {10.1007/s10151-026-03404-7}
}
Kostenlos starten →